Word

PAVE ITS-MCI

Status

Dead

Status Code

402

Status Date

Wednesday, December 21, 2022

Serial Number

79129105

Mark Type

5000

Filing Date

Friday, December 21, 2012

Abandoned Date

Wednesday, December 21, 2022

Trademark Owner History

Genloci Biotechnologies Inc.

Classifications

5 Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietary and nutritional supplements for medical use

1 Protein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purpose; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes

42 Technical research in field of medicines and pharmaceuticals; technical project studies in field of medicines and pharmaceuticals; research and development of new products for others; research in the field of environmental protection; scientific laboratory services; product quality testing; chemist services; chemical research; bacteriological research; biological research

The mark consists of the stylized wording "PAVE ITS-MCI".
Color is not claimed as a feature of the mark.
The wording ""PAVE ITS-MCI" has no meaning in a foreign language.

Trademark Events

Jul 20, 2023

Notification Of Effect Of Cancellation Of Intl Reg Mailed

Jul 20, 2023

Death Of International Registration

Jan 3, 2015

Final Decision Transaction Processed By Ib

Dec 12, 2014

Final Disposition Notice Sent To Ib

Dec 12, 2014

Final Disposition Notice Created, To Be Sent To Ib

Oct 31, 2014

Notification Of Possible Opposition - Processed By Ib

Oct 15, 2014

Notification Of Possible Opposition Sent To Ib

Oct 15, 2014

Notification Of Possible Opposition Created, To Be Sent To Ib

Dec 12, 2013

Abandonment Notice Mailed - Failure To Respond

Dec 12, 2013

Abandonment - Failure To Respond Or Late Response

Jun 5, 2013

Refusal Processed By Ib

May 18, 2013

Application Filing Receipt Mailed

May 16, 2013

Non-Final Action Mailed - Refusal Sent To Ib

May 16, 2013

Refusal Processed By Mpu

May 16, 2013

Non-Final Action (Ib Refusal) Prepared For Review

May 15, 2013

Non-Final Action Written

May 14, 2013

Assigned To Examiner

May 14, 2013

New Application Office Supplied Data Entered

May 13, 2013

Limitation From Original Application Entered

May 9, 2013

Sn Assigned For Sect 66a Appl From Ib